Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis
Clinical trial NCT00017680 · COMPLETED
Trial details
- NCT number
- NCT00017680
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-07-01
- Primary completion
- 2004-04-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.